FDA Issues Emergency Use Authorization for First COVID-19 Vaccine
U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S.
The decision came just a day after an FDA advisory panel voted in favor of authorizing the vaccine. It's to be given in two doses, 3 weeks apart.